Notable for its cross-border patent litigation capabilities, Allen & Overy LLP regularly advises leading pharmaceutical companies, biotechnology groups, and pharmaceutical associations on complex and high-profile issues. The team has considerable expertise across M&A, employment, regulatory, and public law, and is supported by a team of senior science analysts. Practice head Laëtitia Bénard handles a range of contentious and non-contentious IP matters, including disputes regarding patents, trademarks, copyright, and unfair competition. Counsel Charles Tuffreau is dual qualified as a lawyer and a representative before the European Patent Office and is a key name for patent litigation relating to pharmaceutical products and medical technologies.

Dechert LLP is a popular choice for M&A, antitrust, and regulatory advice as well as litigation and arbitration services and is sought out by top life sciences and healthcare companies. The practice is jointly led by private equity specialist Alain Decombe and Mélanie Thill-Tayara, who has a wealth of experience with high-stakes competition matters. Key lawyer Sophie Pelé is also recommended for her ‘sharp and rare expertise’ in the regulatory and public law aspects of the sector.

The life sciences team at Dentons is notable for its transactional work, advising blue-chip industrial clients and top investment funds on major industry challenges and complex regulations. Jean-Marc Grosperrin leads the firm's European life sciences and healthcare group, specialising in both domestic and cross border M&A transactions. The team is jointly led by Grosperrin, tax specialist Julien Le Guyader, and Anne-Laure Marcerou, who has strong expertise in the negotiation of strategic contracts. Pascale Poupelin is also noted for her regulatory work.

Hogan Lovells (Paris) LLP‘s cross-practice life sciences team has deep industry knowledge across corporate, regulatory, data privacy, product liability, and intellectual property matters within the sector. Practice head Mikael Salmela has a wealth of experience in the field, and often advises on regulatory assessments and structuring for M&A transactions. Charlotte Damiano is also noted for her work on pricing and reimbursement disputes for pharmaceutical products and medical devices.

Simmons & Simmons remains a go-to name for complex pharmaceutical product liability matters, as well as advising on intellectual property, data protection, and competition law issues. Alexandre Regniault heads the international life sciences group and handles contentious and transactional work for top pharmaceutical, medical device, and biotech companies. Practice co-head Jacques-Antoine Robert is recognised as a pre-eminent legal authority on product liability disputes, and Ombline Ancelin leads on major competition and regulatory matters.

The interdisciplinary team at Viguié Schmidt & Associés handles regulatory issues, competition, product liability, and commercial disputes for key players in the pharmaceutical market. Etienne Gouesse advises clients on pre-litigation strategy, and has experience before administrative, civil, and commercial courts. Iñaki Saint-Esteben specialises in antitrust law and indemnification requests for facts involving restriction to competition.

The life sciences team at Baker McKenzie stands out for its strengths in corporate M&A transactions, as well as product liability and intellectual property disputes. Drawing on its strong international network, the team acts for pharmaceutical and medical devices companies on cross-border and domestic matters. The practice is headed up by Julie Yéni, who is noted for her 'precision and responsiveness.'

Clifford Chance acts as counsel for a broad range of clients, including pharmaceutical laboratories, financial investors, medical devices manufacturers, as well as manufacturers of cannabis-based products. The team is jointly led by Thomas Baudesson, David Tayar and Olivier Gaillard. The practice’s compliance expertise was strengthened by the arrival of Dominique Laymand as of counsel from an in-house in February 2022. Gaëlle Merlier left the firm.

DLA Piper advises some of the largest global companies and local authorities on data protection, employment, intellectual property, and regulatory issues. Practice head Sonia De Kondserovsky has over 25 years of experience assisting pharmaceutical and medical devices clients on acquisitions and strategic development. Michael Ostrove handles key arbitration and mediation proceedings alongside Frank Valentin, who has a focus on patent litigation. Denise Lebeau-Marianna is a key name for data protection.

The multidisciplinary healthcare and life sciences team at Fieldfisher advises domestic household-name clients and international pharmaceutical companies. The firm also recently partnered with regulatory consultancy MedReg Sciences to provide additional support in the regulatory area. The 'remarkable' Olivier Lantrès leads the team and has particular expertise advising on issues surrounding clinical trials. Nathalie Hadjadj-Cazier handles complex intellectual property matters.

HBC Avocats advises French and international clients on the structuring of transactions and the negotiation of strategic partnerships. The 'very experienced team' is highly skilled in the commercial, contractual, and corporate practices of biopharmaceutical companies, venture capital financing sources, and academic and not-for-profit research and development organisations. The practice is led by Jonathan Burnham, who is dually qualified in New York, and corporate law specialist Erwan Cossé.

Norton Rose Fulbright's cross-practice healthcare and life sciences team provides an integrated commercial M&A, compliance, regulatory, antitrust, and data protection offering. Competition specialist Marta Giner Asins co-leads the team and is noted for litigating in complex cross-border matters. Joint practice head Marion Roquette-Pfister is a public law and regulatory expert, regularly advising on clinical trials, market access, and early access programmes. Nadège Martin leads on intellectual property disputes.

Drawing on the firm's international presence, the team at Herbert Smith Freehills LLP is well known for handling complex cross-border patent litigation, post-merger integration, and restructuring for clients in the life sciences sector. Litigator Frédéric Chevallier heads up the practice in Paris, and is supported by employment specialist Emma Röhsler, who has forged a reputation for complex reputational risk matters.

Jones Day's cross-practice team advises life sciences clients on complex commercial transactions, regulatory disputes, and intellectual property matters. Renaud Bonnet co-leads the firm's global private equity practice, and advises healthcare clients on M&A and capital markets deals. Françoise Labrousse focuses on health and safety compliance investigations and regulatory enforcement litigation.

Latham & Watkins provides a fully integrated life sciences service, advising clients on EU regulatory and compliance matters, corporate transactions, and privacy and antitrust issues. The team assists household name multinational companies and fast-growing startups in the pharmaceutical and biotech space. The 'exceptional and absolutely essential specialist' Eveline Van Keymeulen heads up the practice, and has considerable expertise advising on medical cannabis and hemp-based product regulations.

The 'agile and available team' at Mercure Avocats provides corporate, commercial, and regulatory advice to major players on the French life sciences market. Practice co-head Agathe Simon specialises in M&A transactions, and has additional experience negotiating and drafting complex contractual arrangements. Joint team lead François-Maxime Philizot is a pharmaceutical regulatory expert who handles matters regarding regulations on healthcare products and medical devices.

The life sciences team at Pinsent Masons LLP is well known for supporting disruptive businesses, which it assists with licensing issues, regulatory matters, and antitrust investigations. Emmanuel Gougé heads up the French intellectual property group and has extensive expertise in cross-border patent litigation. Gougé jointly leads the healthcare team with Annabelle Richard, and legal director Jules Fabre, who handles both complex litigation and transactional matters such as R&D agreements for biotechnology companies.

The team at Reed Smith provides high-level strategic advice across the full spectrum of life science and healthcare needs, with particular expertise advising on product liability disputes, competition issues, and regulatory matters. The practice is jointly led by Marianne Schaffner, Daniel Kadar, Marc Lévy, and Natasha Tardif. Isabelle MacElhone is also noted.

Ginestié Magellan Paley-Vincent offers specialist support in health litigation, representing clients in complex civil and criminal cases concerning medical liability, as well as in disciplinary cases against healthcare professionals. The firm also provides advice on corporate governance for private healthcare companies, as well as assisting with medical equipment development investment funds and negotiating healthcare PPP contracts. Nathalie Boudet-Gizardin, a specialist in matters concerning radiology and nuclear medicine, leads the team with medical liability litigator Catherine Paley-Vincent.

Intuity is a boutique healthcare and life sciences firm which specialises in representing major pharmaceuticals companies, including AstraZeneca and Boehringer Ingelheim, in contentious matters including civil claims and administrative disputes. The practice is led by Christophe Hénin, an expert in competition law and the pharmaceuticals regulatory environment. The vastly experienced Alain Gorny, a specialist in healthcare product liability, is also integral to the team.

MCE CARREL's life sciences practice is best known for its advice on clinical trials, IP strategy, and co-development and licensing agreements. The team is co-led by biotechnology specialist Alexandra Carrel who is dual qualified in Geneva. Joint practice head Jeremy Pappalardo was made partner in January 2022, and has expertise in digital IP and contract management for healthcare clients. Mathilde Salavin is also noted.

The life sciences practice at Osborne Clarke assists clients with matters regarding a range of regulations and standards that govern the operations of the health products industry, as well as broader corporate issues and disputes. Regulatory and compliance specialist Thomas Devred leads the team, which was bolstered by the arrival of litigator Joanna Peltzman in 2022.

Squire Patton Boggs has considerable expertise handling complex product liability litigation for pharmaceutical firms and medical devices manufacturers. The practice is also well-placed to advise on mass tort litigation and surgical malpractice claims. The team is jointly led by managing partner Carole Sportes and Valérie Ravit.